Ben Haynor
Stock Analyst at Lake Street
(0.30)
# 4,227
Out of 4,564 analysts
287
Total ratings
34.5%
Success rate
-4.3%
Average return
Main Sectors:
Stocks Rated by Ben Haynor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRTS Sensus Healthcare | Reiterated: Buy | $4.5 | $2.94 | +53.06% | 22 | Jul 9, 2026 | |
| TSX: PRN Profound Medical Corp. | Reiterated: Buy | $16.89 | $9.66 | +74.84% | 33 | Jul 7, 2026 | |
| TOI The Oncology Institute | Initiated Coverage: Buy | $10 | $5.07 | +97.24% | 1 | Jul 6, 2026 | |
| SENS Senseonics Holdings | Maintained: Buy | $12 | $4.87 | +146.41% | 11 | Jun 8, 2026 | |
| NUTX Nutex Health | Initiated Coverage: Buy | $235 | $153.56 | +53.03% | 1 | Jun 2, 2026 | |
| QTI QT Imaging Holdings | Maintained: Buy | $10 | $2.80 | +257.14% | 4 | May 14, 2026 | |
| ELMD Electromed | Reiterated: Buy | $36 | $38.18 | -5.71% | 4 | May 13, 2026 | |
| FEMY Femasys | Reiterated: Buy | $30 | $3.79 | +691.56% | 3 | May 12, 2026 | |
| TMCI Treace Medical Concepts | Reiterated: Buy | $7 | $4.05 | +72.84% | 14 | May 11, 2026 | |
| INFU InfuSystem Holdings | Reiterated: Buy | $18 | $8.89 | +96.85% | 4 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $5.30 | +164.15% | 12 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $5.09 | +57.17% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $15 | $8.21 | +82.70% | 6 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $27.44 | +45.77% | 5 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $18.72 | +81.62% | 7 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.5 | $6.62 | -16.92% | 12 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $4 | $9.31 | -57.04% | 3 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $9.5 | $22.57 | -57.91% | 9 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $3 | $7.03 | n/a | 7 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.00 | n/a | 21 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.9 → $2.9 | $3.23 | n/a | 6 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.5 → $5.5 | $7.47 | n/a | 13 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.33 → $3.15 | $1.85 | n/a | 5 | Feb 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.6 → $7.2 | $0.3995 | n/a | 2 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $19 | $22.88 | n/a | 4 | Nov 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $8.3 | $0.000001 | n/a | 8 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $5.35 | $0.0005 | n/a | 13 | Oct 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $0.5427 | n/a | 1 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $0.9738 | n/a | 1 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.75 → $5.2 | $0.6949 | n/a | 5 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4.3 | $0.0003 | n/a | 1 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $81 | $74.27 | n/a | 1 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $5.55 | $0.5351 | n/a | 2 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $26 | $0.461 | n/a | 3 | Apr 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $0.3124 | n/a | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0002 | n/a | 3 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $233 → $88 | $2.14 | n/a | 7 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $25 → $12 | $7.78 | n/a | 6 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $11 | $2.50 | n/a | 5 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.75 → $6.65 | $1.40 | n/a | 3 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $0.8 → $1.55 | $0.0001 | n/a | 2 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $35 | $158.38 | n/a | 6 | Feb 26, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $70.48 | n/a | 5 | Feb 20, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $539.37 | n/a | 1 | Jan 30, 2014 |
Sensus Healthcare
Jul 9, 2026
Reiterated: Buy
Price Target: $4.5
Current: $2.94
Upside: +53.06%
Profound Medical Corp.
Jul 7, 2026
Reiterated: Buy
Price Target: $16.89
Current: $9.66
Upside: +74.84%
The Oncology Institute
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $5.07
Upside: +97.24%
Senseonics Holdings
Jun 8, 2026
Maintained: Buy
Price Target: $12
Current: $4.87
Upside: +146.41%
Nutex Health
Jun 2, 2026
Initiated Coverage: Buy
Price Target: $235
Current: $153.56
Upside: +53.03%
QT Imaging Holdings
May 14, 2026
Maintained: Buy
Price Target: $10
Current: $2.80
Upside: +257.14%
Electromed
May 13, 2026
Reiterated: Buy
Price Target: $36
Current: $38.18
Upside: -5.71%
Femasys
May 12, 2026
Reiterated: Buy
Price Target: $30
Current: $3.79
Upside: +691.56%
Treace Medical Concepts
May 11, 2026
Reiterated: Buy
Price Target: $7
Current: $4.05
Upside: +72.84%
InfuSystem Holdings
May 8, 2026
Reiterated: Buy
Price Target: $18
Current: $8.89
Upside: +96.85%
May 8, 2026
Reiterated: Buy
Price Target: $14
Current: $5.30
Upside: +164.15%
May 7, 2026
Reiterated: Buy
Price Target: $8
Current: $5.09
Upside: +57.17%
May 6, 2026
Maintained: Buy
Price Target: $25 → $15
Current: $8.21
Upside: +82.70%
May 5, 2026
Reiterated: Buy
Price Target: $40
Current: $27.44
Upside: +45.77%
May 1, 2026
Reiterated: Buy
Price Target: $34
Current: $18.72
Upside: +81.62%
Apr 30, 2026
Maintained: Buy
Price Target: $5.5
Current: $6.62
Upside: -16.92%
Mar 27, 2026
Reiterated: Buy
Price Target: $13 → $4
Current: $9.31
Upside: -57.04%
Jul 29, 2025
Maintained: Buy
Price Target: $15 → $9.5
Current: $22.57
Upside: -57.91%
Jun 3, 2025
Maintained: Buy
Price Target: $4 → $3
Current: $7.03
Upside: n/a
Mar 11, 2025
Rated: Hold
Price Target: n/a
Current: $1.00
Upside: n/a
Mar 20, 2024
Maintained: Buy
Price Target: $1.9 → $2.9
Current: $3.23
Upside: n/a
Feb 23, 2024
Maintained: Buy
Price Target: $2.5 → $5.5
Current: $7.47
Upside: n/a
Feb 14, 2024
Maintained: Buy
Price Target: $3.33 → $3.15
Current: $1.85
Upside: n/a
Jan 31, 2024
Maintained: Buy
Price Target: $5.6 → $7.2
Current: $0.3995
Upside: n/a
Nov 21, 2023
Maintained: Buy
Price Target: $22 → $19
Current: $22.88
Upside: n/a
Nov 14, 2023
Maintained: Buy
Price Target: $20 → $8.3
Current: $0.000001
Upside: n/a
Oct 13, 2023
Maintained: Hold
Price Target: $18 → $5.35
Current: $0.0005
Upside: n/a
Oct 2, 2023
Initiated Coverage: Buy
Price Target: $19
Current: $0.5427
Upside: n/a
Sep 8, 2023
Initiated Coverage: Buy
Price Target: $15
Current: $0.9738
Upside: n/a
Aug 9, 2023
Maintained: Buy
Price Target: $4.75 → $5.2
Current: $0.6949
Upside: n/a
Jun 9, 2023
Initiated Coverage: Buy
Price Target: $4.3
Current: $0.0003
Upside: n/a
May 26, 2023
Reiterated: Buy
Price Target: $81
Current: $74.27
Upside: n/a
May 19, 2023
Maintained: Buy
Price Target: $10 → $5.55
Current: $0.5351
Upside: n/a
Apr 11, 2023
Maintained: Buy
Price Target: $3 → $26
Current: $0.461
Upside: n/a
Feb 17, 2023
Initiated Coverage: Buy
Price Target: $23
Current: $0.3124
Upside: n/a
Jan 23, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Aug 17, 2022
Maintained: Buy
Price Target: $233 → $88
Current: $2.14
Upside: n/a
Jul 11, 2022
Downgraded: Hold
Price Target: $25 → $12
Current: $7.78
Upside: n/a
May 18, 2021
Maintained: Buy
Price Target: $10 → $11
Current: $2.50
Upside: n/a
Aug 11, 2020
Maintained: Buy
Price Target: $2.75 → $6.65
Current: $1.40
Upside: n/a
Nov 10, 2016
Upgraded: Buy
Price Target: $0.8 → $1.55
Current: $0.0001
Upside: n/a
Feb 26, 2016
Upgraded: Buy
Price Target: $35
Current: $158.38
Upside: n/a
Feb 20, 2014
Downgraded: Sell
Price Target: n/a
Current: $70.48
Upside: n/a
Jan 30, 2014
Downgraded: Sell
Price Target: n/a
Current: $539.37
Upside: n/a